Cargando…
Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations
In Europe, National Immunisation Technical Advisory Groups (NITAGs) were established in most countries to promote evidence-informed decision-making in introducing new or improved vaccines or changing recommendations for existing ones. Still, the role, activities and outcomes of NITAGs have not been...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604541/ https://www.ncbi.nlm.nih.gov/pubmed/37883041 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.43.2300131 |
_version_ | 1785126859606851584 |
---|---|
author | Martinelli, Domenico Quattrone, Filippo Fortunato, Francesca Di Maggio, Elisa Filia, Antonietta Rota, Maria Cristina Lopalco, Pier Luigi Prato, Rosa |
author_facet | Martinelli, Domenico Quattrone, Filippo Fortunato, Francesca Di Maggio, Elisa Filia, Antonietta Rota, Maria Cristina Lopalco, Pier Luigi Prato, Rosa |
author_sort | Martinelli, Domenico |
collection | PubMed |
description | In Europe, National Immunisation Technical Advisory Groups (NITAGs) were established in most countries to promote evidence-informed decision-making in introducing new or improved vaccines or changing recommendations for existing ones. Still, the role, activities and outcomes of NITAGs have not been optimally implemented across Europe. Within the European Joint Action on Vaccination (EU-JAV), we conducted a survey to collect information on decision-making process including the main criteria for the introduction of new vaccines or changes to recommendations on their use. Between December 2021 and January 2022, 13 of the 28 European countries invited participated in an online survey. The criteria ranked as most relevant were disease burden and availability of financial resources. Only one country specified that the NITAG recommendations were binding for the government or the health authority. Vaccinations more often reported for introduction or recommendation changes were those against herpes zoster, influenza, human papillomavirus infection, pneumococcal and meningococcal disease. The planned changes will mainly address children and adolescents (2–18 years) and adults (≥ 45–65 years). Our findings show potential overlaps in the activities of NITAGs between countries; and therefore, collaboration between NITAGs may lead to optimisation of the workload and better use of resources. |
format | Online Article Text |
id | pubmed-10604541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-106045412023-10-28 Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations Martinelli, Domenico Quattrone, Filippo Fortunato, Francesca Di Maggio, Elisa Filia, Antonietta Rota, Maria Cristina Lopalco, Pier Luigi Prato, Rosa Euro Surveill Perspective In Europe, National Immunisation Technical Advisory Groups (NITAGs) were established in most countries to promote evidence-informed decision-making in introducing new or improved vaccines or changing recommendations for existing ones. Still, the role, activities and outcomes of NITAGs have not been optimally implemented across Europe. Within the European Joint Action on Vaccination (EU-JAV), we conducted a survey to collect information on decision-making process including the main criteria for the introduction of new vaccines or changes to recommendations on their use. Between December 2021 and January 2022, 13 of the 28 European countries invited participated in an online survey. The criteria ranked as most relevant were disease burden and availability of financial resources. Only one country specified that the NITAG recommendations were binding for the government or the health authority. Vaccinations more often reported for introduction or recommendation changes were those against herpes zoster, influenza, human papillomavirus infection, pneumococcal and meningococcal disease. The planned changes will mainly address children and adolescents (2–18 years) and adults (≥ 45–65 years). Our findings show potential overlaps in the activities of NITAGs between countries; and therefore, collaboration between NITAGs may lead to optimisation of the workload and better use of resources. European Centre for Disease Prevention and Control (ECDC) 2023-10-26 /pmc/articles/PMC10604541/ /pubmed/37883041 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.43.2300131 Text en This article is copyright of the authors or their affiliated institutions, 2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Perspective Martinelli, Domenico Quattrone, Filippo Fortunato, Francesca Di Maggio, Elisa Filia, Antonietta Rota, Maria Cristina Lopalco, Pier Luigi Prato, Rosa Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations |
title | Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations |
title_full | Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations |
title_fullStr | Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations |
title_full_unstemmed | Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations |
title_short | Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations |
title_sort | role of the national immunisation technical advisory groups in 13 european countries in the decision-making process on vaccine recommendations |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604541/ https://www.ncbi.nlm.nih.gov/pubmed/37883041 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.43.2300131 |
work_keys_str_mv | AT martinellidomenico roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations AT quattronefilippo roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations AT fortunatofrancesca roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations AT dimaggioelisa roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations AT filiaantonietta roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations AT rotamariacristina roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations AT lopalcopierluigi roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations AT pratorosa roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations |